Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Kallioniemi

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Oncotarget|January 9, 2013
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasionLaura Lehtinen, Kirsi Ketola, Rami Mäkelä, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 23, 2005
NMD microarray analysis for rapid genome-wide screen of mutated genes in cancerMaija Wolf, Henrik Edgren, Aslaug Muggerud, et al.
Molecular & Cellular Proteomics : MCP|April 23, 2011
Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impactSuvi-Katri Leivonen, Anne Rokka, Päivi Ostling, et al.
Plos One|November 7, 2013
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cellsVesa Hongisto, Sandra Jernström, Vidal Fey, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 4, 2022
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well platesMichaela Feodoroff, Piia Mikkonen, Mariliina Arjama, et al.
Journal of Cellular and Molecular Medicine|January 30, 2018
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumoursOlli-Pekka Pulkka, John-Patrick Mpindi, Olli Tynninen, et al.
Leukemia & Lymphoma|April 5, 2018
Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemiaPoojitha N Ojamies, Mika Kontro, Henrik Edgren, et al.
Plos One|August 14, 2013
ARLTS1 and prostate cancer risk--analysis of expression and regulationSanna Siltanen, Daniel Fischer, Tommi Rantapero, et al.
BMC Cancer|August 26, 2018
Association of tamoxifen resistance and lipid reprogramming in breast cancerSusanne Hultsch, Matti Kankainen, Lassi Paavolainen, et al.
BMC Medical Genomics|May 13, 2009
Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell lineAslaug Aamodt Muggerud, Henrik Edgren, Maija Wolf, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Oncotarget|January 9, 2013
High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasionLaura Lehtinen, Kirsi Ketola, Rami Mäkelä, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|July 23, 2005
NMD microarray analysis for rapid genome-wide screen of mutated genes in cancerMaija Wolf, Henrik Edgren, Aslaug Muggerud, et al.
Molecular & Cellular Proteomics : MCP|April 23, 2011
Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impactSuvi-Katri Leivonen, Anne Rokka, Päivi Ostling, et al.
Plos One|November 7, 2013
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cellsVesa Hongisto, Sandra Jernström, Vidal Fey, et al.
SLAS Discovery : Advancing Life Sciences R & D|December 4, 2022
Protocol for 3D drug sensitivity and resistance testing of patient-derived cancer cells in 384-well platesMichaela Feodoroff, Piia Mikkonen, Mariliina Arjama, et al.
Journal of Cellular and Molecular Medicine|January 30, 2018
Clinical relevance of integrin alpha 4 in gastrointestinal stromal tumoursOlli-Pekka Pulkka, John-Patrick Mpindi, Olli Tynninen, et al.
Leukemia & Lymphoma|April 5, 2018
Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemiaPoojitha N Ojamies, Mika Kontro, Henrik Edgren, et al.
Plos One|August 14, 2013
ARLTS1 and prostate cancer risk--analysis of expression and regulationSanna Siltanen, Daniel Fischer, Tommi Rantapero, et al.
BMC Cancer|August 26, 2018
Association of tamoxifen resistance and lipid reprogramming in breast cancerSusanne Hultsch, Matti Kankainen, Lassi Paavolainen, et al.
BMC Medical Genomics|May 13, 2009
Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell lineAslaug Aamodt Muggerud, Henrik Edgren, Maija Wolf, et al.
Pageof 19